Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Diseases
83%
Melanoma
73%
Tumor
73%
Metastatic Carcinoma
69%
Recurrent Disease
60%
Overall Survival
53%
Limb Perfusion
50%
Postoperative Complication
50%
Tumor Necrosis Factor
47%
Cancer
46%
Rectum Cancer
45%
Lung
45%
Thromboxane B2
44%
Chemotherapy
43%
Soft Tissue Sarcoma
42%
Limb
39%
Melphalan
39%
Ileo-Anal Pouch
38%
Long-Term Outcome
38%
Bleeding
37%
Thromboxane
37%
Lymph Node
36%
Morbidity
36%
Hepatectomy
36%
Neoadjuvant Therapy
35%
Laparotomy
35%
Malignant Neoplasm
34%
Ischemia
33%
Obstruction
33%
Pancreas Cancer
33%
Lung Injury
33%
Surgical Approach
31%
Neutrophil
31%
Surgeon
31%
Colorectal Liver Metastasis
30%
Surgical Anastomosis
30%
Pancreas Adenocarcinoma
30%
Computer Assisted Tomography
29%
Proctocolectomy
29%
Granulocyte
29%
Leukocyte
27%
Lymph Node Metastasis
27%
Lung Artery Pressure
26%
Laparoscopic Surgery
25%
Desmoid Tumor
25%
Conservative Treatment
24%
Amputation
24%
Drug Megadose
24%
Surgical Technique
24%
Keyphrases
Tumor
58%
Thromboxane
55%
Tumor Necrosis Factor-α
53%
Ischemia
52%
Thromboxane B2 (TXB2)
48%
Isolated Limb Perfusion
45%
Reperfusion
44%
Lung
43%
Lymph
40%
Leukotrienes
39%
Malignant Melanoma
36%
Resection
36%
Overall Survival
33%
Israel
32%
Melphalan
31%
Neutrophils
31%
Metastasis
31%
Polymorphonuclear Leukocytes
29%
Diapedesis
28%
Neoadjuvant
27%
Lung Injury
26%
Risk Factors
26%
Gastrointestinal Tract
25%
Patient Outcomes
24%
Postoperative Complications
24%
Melanoma
23%
Ileal Pouch-anal Anastomosis
23%
FOLFIRINOX
23%
Elderly Patients
23%
Borderline Resectable Pancreatic Cancer
23%
Mean Pulmonary Artery Pressure (mPAP)
22%
Computed Tomography
22%
Neoadjuvant Therapy
21%
Surgical Approach
21%
High Dose
21%
Lymph Node Metastasis
21%
Soft Tissue Sarcoma
20%
Pancreatic Ductal Adenocarcinoma
20%
Sheep
20%
Colorectal Cancer Liver Metastasis (CRCLM)
19%
After Surgery
19%
Bleeding
19%
Medical Center
19%
LTB4
18%
Vascular Permeability
18%
Interleukin-2
18%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
18%
Cytoreductive Surgery
18%
Disease-free Survival
18%
Retroperitoneal Sarcoma
17%